ENSG — The Ensign Group Inc. stock price and chart

Share this page

ENSG

$171.78+1.27%

as of close, Oct 2, 2026

☾ AH $171.78 +1.27%

The Ensign Group Inc.Stock · Health CareNasdaq Composite 0.02%Russell 1000 0.01%US Stock Market 0.01%Russell 3000 0.01%

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDED

20162019202120242026

20.040.060.080.0100.0120.0140.0160.0180.0200.005.0M10.0M$171.78

2026-10-02

Price$171.78

MA20$172.79

MA50$178.75

Vol2.0M

What would $1,000 invested in ENSG be worth today? →

ENSG returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $171.78
Change YTD: -1.39%
Next earnings: Nov 2, 2026
Market cap: 10B2016-12 1.1B2026-10 10B+850.7% over the window
Enterprise value: 11.9B
Shares outstanding: 58.3M2016-06 50.5M2026-06 58.3M+15.5% over the window
52W low: $141.58
52W high: $218.00
From 52W high: -21.20%
From 52W low: +21.33%
52W range: 40%
Beta: 0.69

Volume

Rel volume: 0.95×
30D volume: 344.5K
30D $ vol: 60M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.: none
Insider net 3M0 insider-days of buying (no priced lot) and 3 of selling ($153K) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$153K
Insider net 1Y0 insider-days of buying (no priced lot) and 21 of selling ($4.0M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$4.0M

Form 4 transactions by trade date, as filed; latest on file 2026-07-27.

Fundamentals

Sales (ttm): 5.5B2016-12 1.7B2026-06 5.5B+229.8% over the window
Sales/share: $93.662016-12 $32.512026-06 $93.66+188.1% over the window
EPS (ttm): $6.382016-06 $0.902026-06 $6.38+606.1% over the window
FCF (ttm): 492.7M2015-12 -26.6M2019-12 120.7M-552.9% over the window
FCF/share: $8.452015-12 -$0.532019-12 $2.25-529.1% over the window
Book value/share: $41.892016-06 $8.392026-06 $41.89+399.4% over the window
Net margin: 6.94%2016-12 3.0%2026-06 6.9%+129.7% over the window
ROE: 15.51%2016-06 11.2%2026-06 15.5%+38.1% over the window
ROA: 6.59%2016-06 5.7%2026-06 6.6%+16.3% over the window
Debt / equity: 0.06×2016-06 0.432026-06 0.06-87.2% over the window
Current ratio: 1.212016-06 1.612026-06 1.21-24.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +18.91%2025-06-30 → 2026-06-304.6B → 5.5B (+18.9% total)+17.23%2023-06-30 → 2026-06-303.4B → 5.5B (+61.1% total)+17.10%2021-06-30 → 2026-06-302.5B → 5.5B (+120.2% total)+13.39%2016-12-31 → 2026-06-301.7B → 5.5B (+229.8% total)
Net income: +17.33%2025-06-30 → 2026-06-30322.8M → 378.7M (+17.3% total)+16.34%2023-06-30 → 2026-06-30240.5M → 378.7M (+57.5% total)+15.04%2021-06-30 → 2026-06-30188M → 378.7M (+101.4% total)+23.06%2016-06-30 → 2026-06-3047.6M → 378.7M (+696.1% total)
FCF: -24.31%2018-12-31 → 2019-12-31159.4M → 120.7M (-24.3% total)+145.32%2016-12-31 → 2019-12-318.2M → 120.7M (+1373.7% total)n/an/a
Shares: +1.01%2025-06-30 → 2026-06-3057.7M → 58.3M (+1.0% total)+1.22%2023-06-30 → 2026-06-3056.2M → 58.3M (+3.7% total)+1.12%2021-06-30 → 2026-06-3055.1M → 58.3M (+5.7% total)+1.45%2016-06-30 → 2026-06-3050.5M → 58.3M (+15.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +15.73%2025-06-30 → 2026-06-30$5.51 → $6.38 (+15.7% total)+14.81%2023-06-30 → 2026-06-30$4.22 → $6.38 (+51.3% total)+13.91%2021-06-30 → 2026-06-30$3.33 → $6.38 (+91.8% total)+21.59%2016-06-30 → 2026-06-30$0.90 → $6.38 (+606.1% total)
Sales/share: +17.72%2025-06-30 → 2026-06-30$79.57 → $93.66 (+17.7% total)+15.82%2023-06-30 → 2026-06-30$60.28 → $93.66 (+55.4% total)+15.81%2021-06-30 → 2026-06-30$44.96 → $93.66 (+108.3% total)+11.79%2016-12-31 → 2026-06-30$32.51 → $93.66 (+188.1% total)
FCF/share: -25.49%2018-12-31 → 2019-12-31$3.03 → $2.25 (-25.5% total)+141.23%2016-12-31 → 2019-12-31$0.16 → $2.25 (+1301.2% total)n/an/a
Book value/share: +19.82%2025-06-30 → 2026-06-30$34.97 → $41.89 (+19.8% total)+19.26%2023-06-30 → 2026-06-30$24.69 → $41.89 (+69.7% total)+20.00%2021-06-30 → 2026-06-30$16.84 → $41.89 (+148.8% total)+17.45%2016-06-30 → 2026-06-30$8.39 → $41.89 (+399.4% total)
Dividend/share: +4.04%2025-06-30 → 2026-06-30$0.25 → $0.26 (+4.0% total)+4.21%2023-06-30 → 2026-06-30$0.23 → $0.26 (+13.2% total)+4.41%2021-06-30 → 2026-06-30$0.21 → $0.26 (+24.1% total)+5.04%2016-06-30 → 2026-06-30$0.16 → $0.26 (+63.5% total)
Price: -1.24%2025-10-02 → 2026-10-02$173.93 → $171.78 (-1.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+23.12%2023-10-02 → 2026-10-02$92.04 → $171.78 (+86.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+17.83%2021-10-01 → 2026-10-02$75.62 → $171.78 (+127.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+24.73%2016-09-30 → 2026-10-02$18.83 → $171.78 (+812.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -1.09%2025-10-02 → 2026-10-02$173.67 → $171.78 (-1.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+23.33%2023-10-02 → 2026-10-02$91.57 → $171.78 (+87.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+18.07%2021-10-01 → 2026-10-02$74.85 → $171.78 (+129.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+25.18%2016-09-30 → 2026-10-02$18.17 → $171.78 (+845.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 26.9×2016-12 23.272026-10 26.44+13.6% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 21.4×2016-12 13.082026-10 21.42+63.7% over the window
Fwd P/E: 20.7×
P/S (ttm)Market cap ÷ TTM revenue.: 1.8×2017-03 0.542026-10 1.83+240.4% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 4.1×2016-12 2.412026-10 4.10+70.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 20.3×2016-12 49.532026-10 82.95+67.5% over the window
EV/EBITDA (fy): 20.5×
EV/Sales (ttm): 2.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.92%2016-09 2.0%2019-12 5.0%+146.1% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record, not what was actually paid over the past year. Shown only when the record holds a full payment cycle that agrees with the dividends the company reports paying; otherwise —.: 0.15%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only where the forward yield is; otherwise —.: 0.15%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year.: $0.26
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 58.3M ÷ 57.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -1.01%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.01%) + dividends paid over that year ($14.8M) ÷ market_cap_at(2025-06-30) ($8.9B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -0.84%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($40M) ÷ today's market cap ($10B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.40%2016-09 2.8%2026-06 0.4%-85.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $40M + TTM dividends $14.8M) ÷ today's market cap ($10B). Same caveat as the cash buyback yield.: 0.55%2016-09 3.6%2026-06 0.6%-83.8% over the window

Vs own 10Y history

P/E: 65th
P/OI: 57th
P/S: 74th
P/B: 50th
P/FCF: 85th

Bar = where today’s multiple sits in ENSG’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-02

+1.27%

-1.94%

-0.53%

+2.12%

YTD

-1.39%

-1.24%

+127.16%

Recent filings

Aug 258-K · Charter, bylaws or fiscal-year change
Aug 208-K · Material definitive agreement; New financial obligation; Regulation FD disclosure
Jul 27Earnings · Earnings release — EPS $1.72 vs $1.63 est. (+5.5%); revenue $1.43B (+17% y/y) 2.9%
Jul 27Report · Quarterly report, Q2 2026 — revenue $1.43B (+17% y/y), net income $99.7M, EPS $1.68
Jul 27Insider sale · Blouin Ann Scott (Director) sold 375 shares for $69K at $181.88–$185.00 under a 10b5-1 plan

All filings and insider trades →

Financial statements

Open full ENSG financials →

Loading financial statements…

Ticker	Name	1M	1D
NVS	Novartis AG	-13.21%	-0.04%
NVO	Novo Nordisk A/S	-20.21%	-0.21%
SNY	Sanofi ADS	-10.23%	-1.84%
GSK	GSK plc American Depositary Shares (Each representing two Ordinary Shares)	-6.76%	-0.32%
NTRA	Natera Inc.	+26.20%	+0.46%
ARGX	argenx SE American Depositary Shares	-12.90%	-1.79%
TAK	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	-3.09%	+0.00%
TEVA	Teva Pharmaceutical Industries Limited American Depositary Shares	+5.44%	+0.56%

ENSG — The Ensign Group Inc. price, chart and key statistics